Ratings for Conmed (NYSE:CNMD) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 3 | 1 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $87.83, along with a high estimate of $106.00 and a low estimate of $71.00. A decline of 7.55% from the prior average price target is evident in the current average.
Diving into Analyst Ratings: An In-Depth Exploration
The perception of Conmed by financial experts is...
Login or create a forever free account to read this news
Sign up/Log in
